Submitted by Anonymous (not verified) on 19 February 2026 - 9:23
Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation: 30/06/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation: 30/06/2025, Status: Authorised